Alvotech (ALVOW) Divestments (2021 - 2022)

Alvotech (ALVOW) reported Divestments of $48.6 million for Q4 2022, down 12.18% on a YoY basis from $55.3 million in Q4 2021, and down 12.18% quarter-over-quarter from $55.3 million in Q4 2021.

Alvotech (ALVOW) Divestments (2021 - 2022) Analysis & Trends

Alvotech has reported Divestments for 2 years, with the latest figure at $48.6 million in Q4 2022.

  • For the quarter ending Q4 2022, Divestments fell 12.18% year-over-year to $48.6 million; the trailing twelve-month figure through Dec 2022 stood at $48.6 million (down 12.18% YoY), and the FY2022 full-year result was $48.6 million, down 12.18% from the prior year.
  • Divestments for Q4 2022 stood at $48.6 million, down from $55.3 million in the prior quarter.
  • The five-year high for Divestments was $55.3 million in Q4 2021, with the low at $48.6 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 42.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 63.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 24.21 Mn
10 Alvotech - - -22.39 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 48.57 Mn
Dec 31, 2021 55.31 Mn